The firm is now clinically validating a mass spec-based test for quantifying native insulin and its therapeutic analogs and another test for type 2 diabetes.
The approach brings together the spatial resolution of optical microscope and the rich molecular information generated by imaging mass spectrometry.
Researchers have developed a mathematical framework for forming disease modules based on protein interaction profiles and GWAS data.
The team's dilution experiments suggest Simoa could be thousands of times more sensitive than standard ELISAs in detecting anti-dengue antibodies.
The Australian company has also inked a deal to launch its proteomics-based kidney disease test in China.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.
In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.